These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27397095)

  • 21. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
    Boorjian SA; Kim SP; Tollefson MK; Carrasco A; Cheville JC; Thompson RH; Thapa P; Frank I
    J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of Definitive Prostate Cancer Therapy on Soft Tissue Margins and Survival in Patients Undergoing Radical Cystectomy for Bladder Urothelial Cancer.
    Luchey AM; Lin HY; Yue B; Agarwal G; Gilbert SM; Lockhart J; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ
    J Urol; 2015 Nov; 194(5):1220-5. PubMed ID: 26055823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse health outcomes associated with surgical management of the small renal mass.
    Shuch B; Hanley JM; Lai JC; Vourganti S; Setodji CM; Dick AW; Chow WH; Saigal CS;
    J Urol; 2014 Feb; 191(2):301-8. PubMed ID: 24012580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoption.
    Becker A; Ravi P; Roghmann F; Trinh QD; Tian Z; Larouche A; Kim S; Shariat SF; Kluth L; Dahlem R; Fisch M; Graefen M; Eichelberg C; Karakiewicz PI; Sun M
    Urology; 2014 Jun; 83(6):1285-91. PubMed ID: 24862392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use and outcomes of extended antibiotic prophylaxis in urological cancer surgery.
    Calvert JK; Holt SK; Mossanen M; James AC; Wright JL; Porter MP; Gore JL
    J Urol; 2014 Aug; 192(2):425-9. PubMed ID: 24603103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Simultaneous robot-assisted laparoscopic cystectomy and laparoscopic nephrectomy: first experience on 3 patients with short-term follow-up].
    Peter J; May M; Ahmed AM; Ahmed A; Gilfrich C
    Aktuelle Urol; 2012 Jul; 43(4):255-61. PubMed ID: 22869496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
    Daugherty M; Bratslavsky G
    Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal cell carcinoma in octogenarians: nephron sparing surgery should remain the standard of care.
    Hellenthal NJ; Mansour AM; Hayn MH; Schwaab T
    J Urol; 2011 Feb; 185(2):415-20. PubMed ID: 21167523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does patient age affect survival after radical cystectomy?
    Horovitz D; Turker P; Bostrom PJ; Mirtti T; Nurmi M; Kuk C; Kulkarni G; Fleshner NE; Finelli A; Jewett MA; Zlotta AR
    BJU Int; 2012 Dec; 110(11 Pt B):E486-93. PubMed ID: 22551360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.
    Abdollah F; Sun M; Schmitges J; Thuret R; Bianchi M; Shariat SF; Briganti A; Jeldres C; Perrotte P; Montorsi F; Karakiewicz PI
    J Urol; 2012 Jul; 188(1):73-83. PubMed ID: 22578732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort.
    Abdollah F; Sun M; Schmitges J; Tian Z; Jeldres C; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Eur Urol; 2011 Nov; 60(5):920-30. PubMed ID: 21741762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marital status: a gender-independent risk factor for poorer survival after radical cystectomy.
    Sammon JD; Morgan M; Djahangirian O; Trinh QD; Sun M; Ghani KR; Jeong W; Jhaveri J; Ehlert M; Schmitges J; Bianchi M; Shariat SF; Perrotte P; Rogers CG; Peabody JO; Menon M; Karakiewicz PI
    BJU Int; 2012 Nov; 110(9):1301-9. PubMed ID: 22449122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does partial nephrectomy result in a durable overall survival benefit in the Medicare population?
    Smaldone MC; Egleston B; Uzzo RG; Kutikov A
    J Urol; 2012 Dec; 188(6):2089-94. PubMed ID: 23083877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of patient-reported quality of life outcome questionnaire response rates between patients treated surgically for renal cell carcinoma and prostate carcinoma.
    Thiel DD; Davidiuk AJ; Broderick GA; Arnold M; Diehl N; Tavlarides A; Custer K; Parker AS
    BMC Urol; 2015 Jul; 15():58. PubMed ID: 26126615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of Quality Variations on Patients Undergoing Surgery for Renal Cell Carcinoma: A National Cancer Database Study.
    Lawson KA; Saarela O; Abouassaly R; Kim SP; Breau RH; Finelli A
    Eur Urol; 2017 Sep; 72(3):379-386. PubMed ID: 28511884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
    Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
    BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer.
    Koppie TM; Serio AM; Vickers AJ; Vora K; Dalbagni G; Donat SM; Herr HW; Bochner BH
    Cancer; 2008 Jun; 112(11):2384-92. PubMed ID: 18404699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
    Linder BJ; Thompson RH; Leibovich BC; Cheville JC; Lohse CM; Gastineau DA; Boorjian SA
    BJU Int; 2014 Sep; 114(3):368-74. PubMed ID: 24471825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
    Fairey AS; Jacobsen NE; Chetner MP; Mador DR; Metcalfe JB; Moore RB; Rourke KF; Todd GT; Venner PM; Voaklander DC; Estey EP
    J Urol; 2009 Jul; 182(1):85-92; discussion 93. PubMed ID: 19447413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.